RJ Hamster
BSEM: From Quiet Player to Breakout Name
A message from Huge Alerts
From Niche Regenerative Player to Scalable MedTech Contender: BioStem (BSEM) Combines Clinical Validation, Strong Margins, and Strategic Expansion for 2026 Growth!
BioStem Technologies, Inc. (BSEM) has rapidly transitioned from a niche regenerative medicine company into a broader MedTech platform with expanding commercial reach and validated clinical performance. Its proprietary BioREtain® technology has demonstrated superior outcomes in wound healing through Level 1 clinical data, helping drive adoption across key channels like the VA system, Medicaid programs, and ambulatory care centers.
With demand continuing to build—even amid pricing headwinds—the company is showing it can scale effectively in a competitive and evolving market. A Nasdaq uplisting potentially on the horizon and analyst coverage pointing to valuation upside, BioStem is increasingly difficult to ignore.
The recent BioTissue asset acquisition adds another layer of growth by immediately contributing revenue and opening doors to hospital-based care, while also enhancingBSEM’s sales infrastructure. At the same time, its strong margin profile and history of profitability distinguish it from peers still reliant on external funding.
With a $25.50 price target from Zacks Small Cap Research, BSEM’s current valuation highlights a notable disconnect between market pricing and underlying fundamentals.
Learn why BSEM is gaining traction as a high-conviction name in small-cap MedTech
Today’s Bonus Story
These 2 Bitcoin ETFs Are Seeing Inflows for the First Time in Months
Reported by Nathan Reiff. Publication Date: 3/23/2026.
Key Points
- With Bitcoin trading near one-year lows of around $69,000, institutional investors have poured hundreds of millions of dollars into BTC-focused ETFs in recent weeks.
- iShares Bitcoin Trust has remained the dominant spot Bitcoin ETF by assets and liquidity, while Fidelity’s fund offers a smaller but comparable alternative.
- Expense ratios, liquidity, and daily flow data matter more than headlines, especially amid geopolitics and ongoing crypto volatility.
- Special Report: Iran just changed everything for gold (From Behind the Markets)
Bitcoin, which topped $126,000 last fall, is entering the second quarter of 2026 near a one-year low around $69,000. That lower price may have drawn institutional investors back to digital tokens, even as traditional markets faced stresses related to the Iran war. Indeed, institutions poured more than $458 million into spot Bitcoin exchange-traded funds (ETFs) in a single day in early March.
This marked a reversal of the cryptocurrency fund outflows that dominated the first two months of the year, and it happened with relatively little fanfare while investors focused on oil and gasoline prices and concerns about reigniting inflation. Retail investors may wonder whether the funds that received most of this institutional attention—including the iShares Bitcoin Trust ETF (NASDAQ: IBIT) and the Fidelity Wise Origin Bitcoin Fund (BATS: FBTC)—remain attractive after the flow reversal.
IBIT’s Dominance in the Bitcoin ETF Space Becomes More Evident
Elon Musk already made me a “wealthy man” (Ad)
I Met Elon Musk “Face-to-Face”
During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally.
As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date:
March 26, 2026. Circle it on your calendar.
I’m sharing an “access code” that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade.Click Here to See how to Get Your “SpaceX Access Code”
After roughly $1.8 billion in Bitcoin ETF outflows during the first two months of the year and a sharp drop in the token’s price, crypto investors looked pessimistic heading into March, so the sudden inflows were notable.
The bulk of those inflows went to IBIT, suggesting large institutional buyers are channeling purchases through what is arguably the most popular Bitcoin fund.
For retail investors, it can be tempting to follow institutions that recently moved hundreds of millions of dollars into IBIT. The implication of this collective investment is that a substantial amount of Bitcoin may have shifted into long-term institutional hands—which could tighten available supply for other BTC holders.
IBIT is an attractive option for investors who prefer indirect exposure to Bitcoin. It has a modest expense ratio of 0.12%, which is the trade-off for not having to manage and store BTC directly. The fund is very large, with about $58 billion in assets under management (AUM) and a one-month average trading volume above 63 million.
A Smaller, More Expensive Alternative—But Variety May Be Worthwhile
FBTC is much smaller than IBIT—about $13 billion in AUM and roughly 5.8 million in one-month average trading volume—and it is more expensive, with an expense ratio of 0.25%. Given that, it’s unsurprising FBTC has attracted substantially smaller institutional flows than IBIT. Still, FBTC added $48 million in a single day in early March, which could signal support from retirement account providers and other institutional clients of Fidelity.
The presence of FBTC as a secondary recipient of recent inflows, even at a lower level than IBIT, supports the idea that renewed interest in BTC may be broader and potentially more durable. Fundamentally, FBTC offers a similar proposition to IBIT: Bitcoin exposure with custodial backing.
Despite FBTC’s higher cost and lower liquidity, it may appeal to investors who want to increase Bitcoin exposure without concentrating assets at a single provider. Because both funds track the spot price of Bitcoin, performance should be similar (after accounting for expense-ratio differences), and holding both funds instead of just one may help reduce operational risk.
Investors might also view the institutional signal as a reason to consider alternative ETFs focused on cryptocurrencies. A new BlackRock fund—the iShares Staked Ethereum (ETHB)—launched in March and is the first iShares fund with a staking-yield component, which may attract investors seeking passive-income potential. At the same time, ongoing geopolitical instability could push Bitcoin and other crypto prices up or down, so uncertainty and risks remain.
For more cautious investors, the recent jump in institutional interest in Bitcoin ETFs underscores the value of monitoring fund flows regularly. After a period when institutions appeared to step back from cryptocurrency funds, the recent trend may indicate a broader shift back toward bullishness.
This email communication is a sponsored email provided by Huge Alerts, a third-party advertiser of MarketBeat. Why was I sent this message?.
This message is a paid advertisement for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency and Huge Alerts. American Consumer News, LLC dba MarketBeat receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Sideways Frequency or Huge Alerts. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts’ website for additional information about the relationship between Huge Alerts and BioStem Technologies Inc. (OTC: BSEM).
If you need assistance with your newsletter, please contact our South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC.
345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103-7078. USA..
Today’s Featured Content: 50 years of devastation in less than a decade(From Porter & Company)
